Askina Calgitrol Paste Diabetic Foot Ulcers

Diabetic Foot Ulcer (DFU) Clinical Trial

Official title:
A NON-CONTROLLED PROSPECTIVE COHORT STUDY OF THE USE OF ASKINA® CALGITROL® PASTE + STANDARD OF CARE ON MILDLY INFECTED, NON-ISCHAEMIC DIABETIC FOOT ULCERS

Status Completed

Clinical Trial Summary

The purpose of this study is to assess the efficacy of Askina® Calgitrol® Paste in reducing local infection in subjects treated for mildly infected Diabetic Foot Ulcers (DFU) with Askina® Calgitrol® Paste.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01912092
Study type	Interventional
Source	BBraun Medical SAS
Contact
Status	Completed
Phase	N/A
Start date	April 2013
Completion date	July 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04277598` - A Study to Evaluate Safety and Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot Ulcer	Phase 1/Phase 2
Not yet recruiting	`NCT06449638` - Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs	N/A
Completed	`NCT04372355` - Effect of WF10 (TCDO) on HbA1c Values in Diabetic Foot Ulcer Patients	Phase 2
Terminated	`NCT05438251` - Exploring the Effect of Fespixon Cream for the Treatment of Diabetic Foot Ulcers (TEXAS 3A, 3B)	Phase 4